Drug · DIN 02464985
TEVA-PERINDOPRIL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 7, 2018; first marketed March 7, 2018.
- Drug Identification Number (DIN)
- 02464985
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Perindopril C09AA04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PERINDOPRIL ERBUMINE | 2 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 7, 2018: NOC 20573Abbreviated New Drug Submission (ANDS)
Other DINs named TEVA-PERINDOPRIL
- DIN 02464993 · Marketed
- DIN 02465000 · Marketed